Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02126007 · ClinicalTrials.gov registry record · NA

Fatigue Management in HIV

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
53
Enrollment target

NCT02126007: Completed NA study, sponsored by University of California, San Francisco.

NCT02126007 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02126007, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target

Study Summary

This randomized clinical trial (RCT) pilot study as two main objectives: * determine the overall feasibility of a behavioral intervention for managing fatigue among older adults with HIV infection. * to estimate effect sizes for group differences at 1, 2, and 3 months on five dimensions of fatigue. The investigators hypothesize that adherence, satisfaction, and attrition will be similar for the active intervention group and the attention control group. The investigators also hypothesize that all five dimensions will improve in the intervention group compared to controls over time, and that Cohen's d (Standard Deviation units) will be greater than 0.5 SD units for all five fatigue dimensions at all three post-intervention time points.

Primary Outcome

self-report ratings of morning fatigue severity (Lee Fatigue Scale)

Interventions

  • BEHAVIORAL Sleep and Rhythm Intervention
  • BEHAVIORAL Dietary Modifications

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2014-10
Est. Completion 2015-12
Phase NA

What the finished NCT02126007 record still lists

NCT02126007 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Sleep and Rhythm Intervention is the first listed.

NCT02126007 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02126007 about?

NCT02126007 is a clinical study titled "Fatigue Management in HIV". This randomized clinical trial (RCT) pilot study as two main objectives: * determine the overall feasibility of a behavioral intervention for managing fatigue among older adults with HIV infection. * to estimate effect sizes for group differences at 1, 2, and 3 months on five dimensions of fatigue....

What is the current status of trial NCT02126007?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2014-10. Estimated completion is 2015-12.

What interventions are being tested in trial NCT02126007?

The interventions under investigation include: Sleep and Rhythm Intervention (BEHAVIORAL), Dietary Modifications (BEHAVIORAL).

Who is sponsoring clinical trial NCT02126007?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02126007's enrollment target sits among peer trials

53 1271st of 2000 higher than 729 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04177004 · 53 participants · Phase 1

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

  • NCT04199741 · 53 participants · Phase 1

    PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

  • NCT04835129 · 53 participants · Phase 2

    Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

  • NCT04913805 · 53 participants · Phase 2

    Matching Perfusion and Metabolic Activity in HFpEF

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02126007, the US trial registry maintained by the National Library of Medicine. NCT02126007 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.